Peripheral Vascular Devices Market Size, Share & Industry Analysis, By Product (Vascular Access & Entry Devices {Access Needles, Introducer Sheaths, and Others}, Vascular Navigation & Delivery Devices {Guidewires, Diagnostic Catheters, Guide Catheters, Microcatheters, and Others}, Intravascular Diagnostic & Imaging Devices, Thrombus & Embolus Management Devices, Peripheral Stents, and Others), By Application (Peripheral Arterial Disorders, Aneurysmal Disease, Venous Diseases, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

The global peripheral vascular devices market size was valued at USD 12.04 billion in 2025. The market is projected to grow from USD 12.62 billion in 2026 to USD 19.42 billion by 2034, exhibiting a CAGR of 5.5% during the forecast period.

Peripheral vascular devices are tools used to open or restore blood flow in vessels outside the heart, especially in the legs and arms. In addition, they are also used when blood vessels get narrowed or blocked, which can cause pain while walking, slow wound healing, or in severe cases, risk of limb loss.

The market growth is attributed to rising prevalence of cardiac conditions and lifestyle related diseases that is leading to blood-circulation issues. Moreover, hospitals also prefer treatments that reduce recovery time, hence minimally invasive procedures are becoming more common. In addition, technological advancements is also projected to leverage market growth.

• For instance, in April 2024, Abbott received FDA approval for its Esprit BTK Everolimus eluting resorbable scaffold system. The newly approved devices is designed for blood flow regulation in lower leg.

Furthermore, many key industry players, such as Abbott, Medtronic, Boston Scientific Corporation, Terumo Corporation, and BD operating in the market, are focusing on developing various innovative technologies to offer better products with improved accuracy and efficiency.

PERIPHERAL VASCULAR DEVICES MARKET TRENDS

Expanding Range of Applications for Peripheral Vascular Devices is an Emerging Market Trend

The market is currently witnessing increase in applications of peripheral vascular devices, which is one of the important trend observed in the market. Hospitals are seeing more patients with severe leg circulation problems, especially those linked to diabetes. This is pushing companies to develop devices specifically designed for smaller, harder-to-treat vessels. In addition, as more BTK-focused products receive approvals, hospitals gain confidence to treat complex cases earlier and more effectively.

• For instance, in January 2024, Reflow Medical received CE approval for its spur peripheral retrievable stent system. The new device is introduced for treatment of complex peripheral arterial disease, including below-the-knee vessels.

Download Free sample to learn more about this report.

MARKET DYNAMICS

MARKET DRIVERS

Increasing Burden of Periphery Artery Disease to Accelerate Market Growth

An increasing burden of periphery artery disease is prominently driving the peripheral vascular devices market growth. In addition, certain factors such as lifestyle change, occurrence of blood-circulation conditions are boosting market growth. As hospitals see more PAD cases, they adopt newer tools that can improve outcomes and reduce repeat procedures. This demand results in companies looking for new product clearances and expansions.

• For instance, in June 2021, an estimated 236 million adults worldwide were suffering from peripheral artery disease.

MARKET RESTRAINTS

Need for Safety and Considerable Scrutiny is Expected to Hamper Market Growth

Peripheral vascular devices face strong scrutiny as they are used in critical blood vessels, and hospitals want clear proof of safety and benefit before switching products. This slows adoption, increases clinical study requirements and can delay launches across countries. In practice, even when devices are already used, the industry keeps responding to safety monitoring and updates from regulators.

MARKET OPPORTUNITIES

Rising Emphasis on Minimally Invasive Surgery is Projected to Offer Lucrative Market Growth Opportunities

The market is witnessing growing priority for minimally invasive surgeries to reduce patient recovery time, procedure-related complications and length of stay. In addition, compared to open surgery, minimally invasive treatments are preferred by both clinicians and patients, which supports higher procedure volumes and repeat use of peripheral vascular devices. As hospitals expand cath labs and endovascular suites, demand for a broader range of peripheral devices continues to rise.

MARKET CHALLENGES

Pricing Pressure is Likely to Pose a Critical Challenge to Market Growth

The market is witnessing strong pricing pressure, especially in hospitals that buy through tenders or group purchasing systems, posing a critical challenge for market growth. Moreover, when hospitals evaluate multiple similar devices, price becomes a key deciding factor, which can limit margins for manufacturers and reduce the willingness to invest heavily in sales support. This also creates longer negotiation cycles and forces companies to offer discounts, bundled pricing, or extended service terms to win contracts.

Segmentation Analysis

By Product

Superior Treatment by Peripheral Stents for Lower Leg Complications to Drive Segment Growth

Based on the product, the market is divided into vascular access & entry devices, vascular navigation & delivery devices, intravascular diagnostic & imaging devices, thrombus & embolus management devices, peripheral stents and others.

The peripheral stent segment is anticipated to account for the largest peripheral vascular devices market share. Majority of the healthcare institutions prefer peripheral stents due to its superior treatment outcomes. In addition, these are also used across a wide range of patient severity, so volumes remain steady. Moreover, increasing number of product launches coupled with technological advancements is also projected to leverage segment growth during the forecast period.

• For instance, in March 2023, Getinge received FDA approval for its iCast, a peripheral covered stent.

The thrombus & embolus management devices segment is anticipated to rise with a CAGR of 6.6% over the forecast period.  

To know how our report can help streamline your business, Speak to Analyst

By Application

Substantial Prevalence of Peripheral Arterial Disorders to Accelerate Segment Growth

Based on application, the market is segmented into peripheral arterial disorders, aneurysmal disease, venous diseases and others.

In 2025, the peripheral arterial disorders segment dominated the global market. The segment growth is attributed to substantial prevalence of peripheral artery disease across the globe and adoption of peripheral devices for its treatment due to superior treatment outcomes. In addition, rising investments by companies as well as government authorities to contain cardiac conditions is also estimated to have a positive impact on the segment growth.

The venous diseases segment is anticipated to rise with a CAGR of 6.1% over the forecast period.  

By End-User

Higher Volume of Peripheral and Cardiac Surgeries in Hospitals to Boost Segment Growth

Based on end-user, the market is segmented into hospitals, specialty clinics and others.

In 2025, hospitals segment held highest market share. Hospitals segment leads as most peripheral vascular procedures require imaging support, specialist teams and post-procedure monitoring, especially for complex PAD and urgent cases. Hospitals also handle referrals and advanced care, so they drive higher device volumes compared to smaller centers. In addition, many new technologies are first adopted in hospital settings before wider spread. Furthermore, the segment is set to hold 61.8% share in 2026.

In addition, specialty clinics segment is projected to grow at a CAGR of 5.8% during the study period.

Peripheral Vascular Devices Market Regional Outlook

By geography, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America held the dominant share in 2024, valuing at USD 4.70 billion, and maintained the leading share in 2025, with USD 4.91 billion. The market in North America is expected to increase due to higher emphasis on minimally invasive surgeries, rising incidence of diabetes, and development in bio-absorbable stents.

U.S Peripheral Vascular Devices Market

Based on North America’s strong contribution, the U.S. market can be analytically approximated at around USD 4.39 billion in 2026, accounting for roughly 34.8% of global sales.

Europe

Europe is projected to record a growth rate of 5.0% in the coming years, which is the second highest among all regions, and reach a valuation of USD 3.41 billion by 2026. The region is estimated to witness considerable market growth due to rising investments for new product development, and growing incidence of venous disease.

U.K Peripheral Vascular Devices Market

The U.K. market in 2026 is estimated at around USD 0.55 billion, representing roughly 4.4% of global revenues.

Germany Peripheral Vascular Devices Market

Germany’s market is projected to reach approximately USD 0.77 billion in 2026, equivalent to around 6.1% of global sales.

Asia Pacific

Asia Pacific is estimated to reach USD 2.87 billion in 2026 and secure the position of the third-largest region in the market. Improving healthcare infrastructure coupled with favorable reimbursement policies are estimated to accelerate regional growth.

Japan Peripheral Vascular Devices Market

The Japan’s market in 2026 is estimated at around USD 0.50 billion, accounting for roughly 3.9% of global revenues.

China Peripheral Vascular Devices Market

China’s market is projected to be one of the largest worldwide, with 2026 revenues estimated at around USD 0.95 billion, representing roughly 7.6% of global sales.

India Peripheral Vascular Devices Market

The India’s market in 2026 is estimated at around USD 0.64 billion, accounting for roughly 6.7% of global revenues.

Latin America and Middle East & Africa

The Latin America and Middle East & Africa regions are expected to witness moderate growth during the forecast period. The Latin America market is set to reach a valuation of USD 0.80 billion in 2026. In the Middle East & Africa, the GCC is set to reach a value of USD 0.15 billion in 2026.

South Africa Peripheral Vascular Devices Market

The South Africa market is projected to reach around USD 0.55 billion in 2026, representing roughly 0.48% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Increasing Investments by Key Players in Technology Upgradation to Boost Market Progress

The global peripheral vascular devices market holds a semi-consolidated market structure, constituting prominent players such as Abbott, Medtronic, Boston Scientific Corporation, Terumo Corporation, and BD. The significant market share of these companies is due to numerous strategic activities, including massive investments and product approvals.

• For instance, in July 2025, Teleflex Incorporated completed the acquisition of Biotronik’s vascular intervention business.

Other notable players in the market are Cook Medical, Cardinal Health, Teleflex Incorporated, Merit Medical Systems, and Getinge. These companies are expected to prioritize collaborations to increase share during the forecast period.

LIST OF KEY PERIPHERAL VASCULAR DEVICES COMPANIES PROFILED

• Abbott (U.S.)
• Medtronic (Ireland)
• Boston Scientific Corporation (U.S.)
• Terumo Corporation (Japan)
• BD (U.S.)
• Cook Medical (U.S.)
• Cardinal Health (U.S.)
• Teleflex Incorporated (U.S.)
• Merit Medical Systems (U.S.)
• Getinge AB (Sweden)
• L. Gore & Associates (U.S.)

KEY INDUSTRY DEVELOPMENTS

• August 2025: Abbott received CE approval for its dissolving stents for peripheral vascular treatment.
• March 2025: Vasorum received FDA approval for its Celt ACD plus vascular closure device. The new device is especially designed for puncture closure after percutaneous catheter-based vascular procedures.
• June 2024: Philips announced launch of its new duo venous stent system. The new device is designed for treatment of venous outflow obstruction.
• February 2024: BIOTRONIK and IMDS entered into a strategic collaboration in order to launch technologically advanced Micro Rx catheter.
• November 2022: Genesis MedTech Group received FDA approval for its Chocolate Touch DCB for treatment of peripheral artery disease.

REPORT COVERAGE

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation